Investment

New York and Houston family dynasties co-invest in eye-disease biotech

Two dynastic family offices from opposite ends of the US have invested in a biotech developing regenerative therapies for eye diseases, as family offices continue to concentrate on life science investments. 

Subscribe

You will need a Premium+ Subscription to read this article.

Exclusive news, analysis and research on global family enterprise and private investment offices

SUBSCRIBE TODAY

Already have an account? Sign in

You need a Premium subscription.

To read Premium articles please subscribe.

SUBSCRIBE TODAY

Already have an account? Sign in

You've reached the end.

Continue reading free articles by registering as a Member.
Or choose a Premium Plan.

SUBSCRIBE TODAY

Already have an account? Sign in

Leave a Reply